Literature DB >> 24584305

The expanding clinical spectrum of torpedo maculopathy.

Richard Trevino1, Salma Kiani, Praneetha Raveendranathan.   

Abstract

PURPOSE: Torpedo maculopathy is an idiopathic, congenital, oval-shaped region of chorioretinal hypopigmentation located temporal to the macula. Torpedo lesions are typically unilateral, occasionally harbor an intraretinal cleft, and may be associated with varying degrees of hyperpigmentation. Visual acuity is usually normal, but the lesion may produce a scotoma in the visual field. There are no known associated systemic or ocular abnormalities. Diagnosis is based upon recognition of its characteristic shape and location. Because of its nonprogressive and generally benign nature, no treatment is required. CASE REPORTS: Two cases of torpedo maculopathy associated with fundus excavation are presented. To the best of our knowledge, this is the first reported association of torpedo maculopathy with fundus excavation. In one case, the visual acuity remained unaffected and in the other case the visual acuity was reduced to 20/50. In both cases, optical coherence tomography clearly demonstrates the excavated nature of the torpedo lesions. In case 1, where the visual acuity was normal, the excavation is remote from the fovea but in case 2, where the visual acuity was 20/50, the excavation encroaches upon the fovea. In both cases, a scotoma corresponding to the excavated region could be demonstrated.
CONCLUSIONS: Torpedo maculopathy is a usually benign condition associated with normal visual acuity and normal visual fields. Our cases demonstrate that torpedo maculopathy may be associated with excavation of the fundus and a corresponding scotoma in the visual field. Visual acuity may be compromised should the excavation encroach upon the central fovea. Knowledge of this previously unreported clinical manifestation of torpedo maculopathy may aid in advancing the understanding of this condition and the care of patients with the disorder.

Entities:  

Mesh:

Year:  2014        PMID: 24584305     DOI: 10.1097/OPX.0000000000000181

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  7 in total

Review 1.  Congenital focal abnormalities of the retina and retinal pigment epithelium.

Authors:  Yingna Liu; Anthony T Moore
Journal:  Eye (Lond)       Date:  2020-05-04       Impact factor: 3.775

2.  Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population.

Authors:  Katherine Shirley; Marie O'Neill; Rachel Gamble; Anne Ramsey; Eibhlin McLoone
Journal:  Eye (Lond)       Date:  2018-03-20       Impact factor: 3.775

3.  Clinical evaluation of torpedo maculopathy in an infant population with additional genetic testing for NEXMIF mutation.

Authors:  Gokhan Celik; Murat Gunay; Asli Vural; Osman Kizilay; Yasemin Kendir Demirkol; Muhammet Kazim Erol
Journal:  Eye (Lond)       Date:  2021-07-29       Impact factor: 4.456

4.  Structural-functional correlation using adaptive optics, visual fields, optical coherence tomography and multifocal electroretinogram in a case of torpedo maculopathy.

Authors:  Ramesh Venkatesh; Naresh K Yadav; Shivani Sinha; Ruchir Mehta; Mukunda C Akkali
Journal:  Indian J Ophthalmol       Date:  2019-09       Impact factor: 1.848

Review 5.  Distribution patterns of torpedo maculopathy: Further evidence of a congenital retinal nerve fiber layer-driven etiology.

Authors:  Parker J Williams; Sherveen Salek; Robert A Prinzi; Chris Bergstrom; G Baker Hubbard
Journal:  Saudi J Ophthalmol       Date:  2019-08-27

6.  Hyperpigmented Torpedo Maculopathy with Pseudo-Lacuna: A 5-Year Follow-Up.

Authors:  Austin Rohl; Sushma Vance
Journal:  Case Rep Ophthalmol       Date:  2016-05-26

7.  Commentary: Inner retinal excavation in torpedo maculopathy and proposed type 3 lesions in optical coherence tomography.

Authors:  Koushik Tripathy; Barsha Sarma; Shahana Mazumdar
Journal:  Indian J Ophthalmol       Date:  2018-08       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.